In Vitro Diagnostics (IVD) Market Outlook in China

Regular Price: USD 4,950

Special Price USD 4,208

15% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 4,208

PAY BY INVOICE

Be the first to review this product

The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by understanding the market dynamics and trends. The market can be divided into segments such as clinical chemistry, immunoassay, molecular biology diagnostics, microbiology, coagulation, and hematology. The study covers the period 2007-2016.

Table of Contents

Executive SummaryExecutive SummaryExecutive Summary (continued)Executive Summary—Market Engineering MeasurementsPast, Present, and Future IVD Market in ChinaSnapshot of Potential OpportunitiesOpportunities in Emerging SegmentsMarket OverviewMarket Overview—Segmentation by Testing PrincipleMarket Overview—Segmentation(continued)Market Overview—Segmentation (continued)Market Life CycleHealthcare Structure and Financing in ChinaOverview of the Chinese Medical Insurance SystemOverview of the Chinese Medical Insurance System (continued)Approval of IVD ProductsProcurement of IVD ProductsReimbursement and Price CapsIn Vitro Diagnostics OverviewExternal Challenges: Drivers and Restraints—Total IVD MarketDrivers and RestraintsDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Drivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Total IVD Market ForecastTotal IVD Market —Market Engineering MeasurementsForecast AssumptionsTotal IVD Market—Revenue ForecastRevenue Forecast DiscussionCompetitive AnalysisMultinational and Local ParticipantsForeign enterprises have already achieved stable market sharesLeading Local suppliers more flexible on their sales strategyDistribution Model of IVD IndustryFeature Analysis of the Chinese Health Institution and Central LabsDevelop substitution for imported devices: short-cut for local leading manufacturersCompetitive Analysis—Market ShareMarket Share AnalysisMarket Share Analysis(continued)Molecular Diagnostics Segment Molecular Diagnostics Segment—Revenue ForecastMolecular Diagnostics Segment—Revenue Forecast DiscussionClinical Chemistry SegmentClinical Chemistry Segment—Revenue ForecastClinical Chemistry Segment—Revenue Forecast DiscussionImmunoassay SegmentImmunoassay Segment—Revenue ForecastImmunoassay Segment—Revenue Forecast DiscussionMicrobiologyMicrobiology Segment—Revenue ForecastMicrobiology Segment—Revenue Forecast DiscussionPOCTSegmentPOCT Segment—Revenue ForecastPOCT Segment—Revenue Forecast DiscussionCoagulationSegmentCoagulation Segment—Revenue ForecastCoagulation Segment—Revenue Forecast DiscussionSMBGSegment Revenue ForecastSMBG Segment—Revenue ForecastSMBG Segment—Revenue Forecast DiscussionHematology Hematology Segment—Revenue ForecastHematology Segment—Revenue Forecast DiscussionConclusions and RecommendationsConclusionsRecommendationsLegal DisclaimerThe Frost & Sullivan StoryWho is Frost & SullivanWhat Makes Us UniqueTEAM MethodologyOur Global Footprint 40+ Offices




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.